Insulin Delivery Systems Market Analysis (2008-2012)

Table of Contents

1. Analyst View

2. Global Diabetes Drug Market

3. Global Insulin Market

• 3.1 India
  • 3.1.1 Prevalence
  • 3.1.2 Market Analysis
• 3.2 China
  • 3.2.1 Prevalence
  • 3.2.2 Market Analysis
• 3.3 US
  • 3.3.1 Prevalence
  • 3.3.2 Market Analysis
• 3.4 Russia
  • 3.4.1 Prevalence
  • 3.4.2 Market Analysis
• 3.5 Japan
  • 3.5.1 Prevalence
  • 3.5.2 Market Analysis
• 3.6 Germany
  • 3.6.1 Prevalence
  • 3.6.2 Market Analysis
• 3.7 Pakistan
  • 3.7.1 Prevalence
  • 3.7.2 Market Analysis
• 3.8 Brazil
  • 3.8.1 Prevalence
  • 3.8.2 Market Analysis
• 3.9 Mexico
  • 3.9.1 Prevalence
• 3.10 Egypt
  • 3.10.1 Prevalence

4. Insulin Delivery Devices

• 4.1 Present Devices
  • 4.1.1 Insulin Pens
    • 4.1.1.1 Mechanism and Technologies
    • 4.1.1.2 Market Analysis
      • 4.1.1.2.1 Global
      • 4.1.1.2.2 US
      • 4.1.1.2.3 Europe
      • 4.1.1.2.4 Japan
    • 4.1.1.3 Pros and Cons
    • 4.1.1.4 Key Players
  • 4.1.2 Insulin Pumps
    • 4.1.2.1 Mechanism and Technologies
    • 4.1.2.2 Market Analysis
      • 4.1.2.2.1 Global
      • 4.1.2.2.2 US
      • 4.1.2.2.3 Non US
    • 4.1.2.3 Pros and Cons
    • 4.1.2.4 Key Players
  • 4.1.3 Insulin Syringes
    • 4.1.3.1 Mechanism and Technology
    • 4.1.3.2 Market Analysis
    • 4.1.3.3 Pros and Cons
    • 4.1.3.4 Future Outlook (2010-2012)
  • 4.1.4 Insulin Jet Injectors
    • 4.1.4.1 Mechanism and Technologies
    • 4.1.4.2 Market Analysis
    • 4.1.4.3 Pros and Cons
    • 4.1.4.4 Future Outlook (2010-2012)
• 4.2 Future Devices
  • 4.2.1 Oral Insulin
  • 4.2.2 Insulin Patch
  • 4.2.3 Implantable Insulin Pumps

5. Key Market Trends and Restraints

• 5.1 Convenient and Less Painful Modes of Insulin Delivery
• 5.2 Improved Access and Lower Insulin Prices in the Developing World
• 5.3 US and Developing Countries - Potential Markets for Insulin Syringes
• 5.4 High R&D and Production Cost
• 5.5 Insurance Reimbursement

6. Key Players

• 6.1 Eli Lilly & Company
• 6.2 Novo Nordisk A/S
• 6.3 Sanofi-Aventis
• 6.4 Becton, Dickinson and Company
• 6.5 Medtronic, Inc.

List of Figures:

• Figure 2-1: Global - Number of Diabetic Patients (Million), 2007 & 2025
• Figure 2-2: Global - Diabetes Drugs Market (Billion US$), 2007-2009
• Figure 2-3: US - Top 5 Anti-diabetic Drugs (Billion Euro)
• Figure 2-4: EU - Top 5 Anti-diabetic Drugs (Million Euro)
• Figure 3-1: Global - Insulin Market (Billion US$), 2007-2009
• Figure 3-2: Global - Forecast for Insulin Market (Billion US$), 2010-2012
• Figure 3-3: Global - Insulin Demand (Kg), 2006 & 2012
• Figure 3-4: India - Number of Diabetic Patients (Million), 2008 & 2030
• Figure 3-5: India - Insulin Market (Million US$), 2007-2009
• Figure 3-6: India - Share of Key Players in Insulin Market (2008)
• Figure 3-7: China - Insulin Market (Million US$), 2007-2009
• Figure 3-8: China - Share of Key Players in Insulin Market (Q4 2008)
• Figure 3-9: US - Share of Key Players in Insulin Market (2008)
• Figure 3-10: Russia - Insulin Market (Million US$), 2007-2009
• Figure 3-11: Russia - Share of Key Players in Insulin Market (H1 2006)
• Figure 3-12: Russia - Insulin Market by Channel of Sales (%), 2007
• Figure 3-13: Japan - Insulin Market (Billion JPY), 2007-2009
• Figure 3-14: Japan - Share of Novo Nordisk in Insulin Market (2008)
• Figure 3-15: Germany - Insulin Market (Billion US$), 2007-2009
• Figure 3-16: Brazil - Insulin Market (Million BRL), 2007-2009
• Figure 4-1: Global, US, Europe & Japan - Insulin Units Delivered through Pen Devices (%), 2006
• Figure 4-2: US - Insulin Pen Devices Market (Million US$), 2007-2009
• Figure 4-3: US - Forecast for Insulin Pen Devices Market (Million US$), 2010-2012
• Figure 4-4: US - Insulin Units Delivered through Pen Devices (%), 2004 & 2006-2008
• Figure 4-5: US - Share of Disposable and Refillable Pen Devices (2006)
• Figure 4-6: Europe - Insulin Units Delivered through Pen Devices (%), 2004, 2006-2008
• Figure 4-7: Europe - Share of Disposable and Refillable Pen Devices (2006)
• Figure 4-8: Japan - Insulin Units Delivered through Pen Devices (%), 2004 & 2006-2008
• Figure 4-9: Global - Share of Key Players in Pen Devices Market (2005)
• Figure 4-10: Global - Insulin Pumps and Disposables Market (Million US$), 2007-2009
• Figure 4-11: Global - Forecast for Insulin Pumps and Disposables Market (Million US$), 2010-2012
• Figure 4-12: Global - Share of US and Non US in Insulin Pumps and Disposables Market (2008)
• Figure 4-13: Global - Forecast for Share of US and Non US in Insulin Pumps and Disposables Market (2012)
• Figure 4-14: US - Insulin Pumps and Disposables Market (Million US$), 2007-2009
• Figure 4-15: US - Forecast for Insulin Pumps and Disposables Market (Million US$), 2010-2012
• Figure 4-16: US - Insulin Pump Sales (‘000 Units), 2004, 2008 & 2012
• Figure 4-17: Non US - Insulin Pumps and Disposables Market (Million US$), 2007-2009
• Figure 4-18: Non US - Forecast for Insulin Pumps and Disposables Market (Million US$), 2010-2012
• Figure 4-19: Global - Share of Key Players in Insulin Pumps Market (2008)
• Figure 4-20: US - Share of Key Players in Insulin Pumps Market (2008)
• Figure 4-21: Europe - Share of Key Players in Insulin Pumps Market (2008)
• Figure 4-22: Japan - Share of Nipro in Insulin Pumps Market (2005)
• Figure 4-23: US - Insulin Syringes Market (Million US$), 2007-2009
• Figure 4-24: US - Share of Insulin Syringes Market (2005 & 2007-2009)
• Figure 4-25: US - Forecast for Insulin Syringes Market (Million US$), 2010-2012
• Figure 4-26: US - Forecast for Share of Insulin Syringes Market (2010-2012)
• Figure 4-27: Global - Insulin-driven Jet Injectors Market (Million US$), 2007-2009
• Figure 4-28: US - Insulin-driven Jet Injectors Market (Million US$), 2007-2009
• Figure 4-29: US - Share of Insulin-driven Jet Injectors Market (2007-2009)
• Figure 4-30: Global - Forecast for Insulin-driven Jet Injectors Market (Million US$), 2010-2012
• Figure 4-31: US - Forecast for Insulin-driven Jet Injectors Market (Million US$), 2010-2012
• Figure 4-32: US - Forecast for Share of Insulin-driven Jet Injectors Market (2010-2012)

List of Tables:

• Table 2-1: Global - List of Top Anti-diabetic Brands (2008)
• Table 3-1: India - Diabetic Patients in Age Group 20-79 Years (‘000), 2007
• Table 3-2: India - Forecast for Diabetic Patients in Age Group 20-79 Years (‘000), 2025
• Table 3-3: China - Diabetic Patients in Age Group 20-79 Years (' 000), 2007
• Table 3-4: China - Forecast for Diabetic Patients in Age Group 20-79 Years (' 000), 2025
• Table 3-5: US - Diabetic Patients in Age Group 20-79 Years (' 000), 2007
• Table 3-6: US - Forecast for Diabetic Patients in Age Group 20-79 Years (' 000), 2025
• Table 3-7: Russia - Diabetic Patients in Age Group 20-79 Years (' 000), 2007
• Table 3-8: Russia - Forecast for Diabetic Patients in Age Group 20-79 Years (' 000), 2025
• Table 3-9: Japan - Diabetic Patients in Age Group 20-79 Years (' 000), 2007
• Table 3-10: Japan - Forecast for Diabetic Patients in Age Group 20-79 Years (' 000), 2025
• Table 3-11: Germany - Diabetic Patients in Age Group 20-79 Years (' 000), 2007
• Table 3-12: Germany - Forecast for Diabetic Patients in Age Group 20-79 Years (' 000), 2025
• Table 3-13: Pakistan - Diabetic Patients in Age Group 20-79 Years (' 000), 2007
• Table 3-14: Pakistan - Forecast for Diabetic Patients in Age Group 20-79 Years (' 000), 2025
• Table 3-15: Brazil - Diabetic Patients in Age Group 20-79 Years (' 000), 2007
• Table 3-16: Brazil - Forecast for Diabetic Patients in Age Group 20-79 Years (' 000), 2025
• Table 3-17: Mexico - Diabetic Patients in Age Group 20-79 Years (' 000), 2007
• Table 3-18: Mexico - Forecast for Diabetic Patients in Age Group 20-79 Years (' 000), 2025
• Table 3-19: Egypt - Diabetic Patients in Age Group 20-79 Years (‘000), 2007
• Table 3-20: Egypt - Forecast for Diabetic Patients in Age Group 20-79 Years (' 000), 2025